Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
This article is part of Med Tech Outlook's Innovation Insights series featuring expert contributions nominated by our subscribers and reviewed by our editorial team.
Asaf Bar, CEO , Vibrant Gastro
Editor’s Note: Enterprise healthcare leaders are under pressure to move beyond drug-centric models toward scalable, patient-centric therapies that deliver measurable outcomes. This perspective underlines the strategic shift toward bioelectronic and data-enabled treatments that align with the body’s natural systems while opening new frontiers in digital therapeutics.
Where Innovation Meets Compassion
The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info
